The recent cold weather in St. Louis has me anticipating a trip in early March (3rd-4th) to sunny La Jolla, California, where I will attend and speak at the Future of Genomic Medicine (FOGM) IX meeting. As always, FOGM has a highly unique format that conveys the latest results from translational genomic (aka "precision") medicine, with the goal of aiding clinicians and researchers in making clinical decisions of individual patients more precise and personal. The meeting informs participants about how next-generation sequencing methods and analytical computational analyses can be combined for clinically relevant studies ushering genomics into evidence-based medicine. The meeting also provides perspectives on the social impact of genomic medicine as told by journalists, media personalities, and advocates. In the session on cancer, I will discuss our newest technological advances to understand the changes in DNA alterations and RNA expression that occur during cancer progression and provide specific examples from patients on how these data can influence clinical care.
